Global to push GA events into
skip to main content

Title: Peptide and protein biomarkers for type 1 diabetes mellitus

A method for identifying persons with increased risk of developing type 1 diabetes mellitus, or having type I diabetes mellitus, utilizing selected biomarkers described herein either alone or in combination. The present disclosure allows for broad based, reliable, screening of large population bases. Also provided are arrays and kits that can be used to perform such methods.
Inventors:
;
Issue Date:
OSTI Identifier:
1134213
Assignee:
Battelle Memorial Institute (Richland, WA) RLO
Patent Number(s):
8,748,352
Application Number:
13/586,321
Contract Number:
AC05-76RL01830
Resource Relation:
Patent File Date: 2012 Aug 15
Research Org:
Pacific Northwest National Lab. (PNNL), Richland, WA (United States)
Sponsoring Org:
USDOE
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES

Works referenced in this record:

Biological activities of C1 inhibitor
journal, October 2008

Development of a fibrinogen-specific sandwich enzyme-linked immunosorbent assay microarray assay for distinguishing between blood plasma and serum samples
journal, July 2011
  • Gonzalez, Rachel M.; Zhang, Qibin; Zangar, Richard C.
  • Analytical Biochemistry, Vol. 414, Issue 1, p. 99-102
  • DOI: 10.1016/j.ab.2011.02.039

Transthyretin constitutes a functional component in pancreatic β-cell stimulus-secretion coupling
journal, November 2005
  • Refai, E.; Dekki, N.; Yang, S.-N.
  • Proceedings of the National Academy of Sciences, Vol. 102, Issue 47, p. 17020-17025
  • DOI: 10.1073/pnas.0503219102

Targeted proteomic strategy for clinical biomarker discovery
journal, December 2008

The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
journal, October 2007
  • Wenzlau, J. M.; Juhl, K.; Yu, L.
  • Proceedings of the National Academy of Sciences, Vol. 104, Issue 43, p. 17040-17045
  • DOI: 10.1073/pnas.0705894104